Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Christine Silverstein as director of investor relations, effective immediately. She will report to Michael Becker, senior vice president of finance and corporate development at Relmada.
Relmada Therapeutics Appoints Michael Becker as Senior Vice President of Finance and Corporate Development
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Michael D. Becker as senior vice president of finance and corporate development, effective immediately.
Relmada Therapeutics, Inc. Appoints Christopher W. James as Senior Director of Clinical Development
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development.
Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for Levocap ER
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of LevoCap ER, a new tamper-resistant, extended release form of levorphanol. Gavril Pasternak, MD, PhD, of MSKCC is the lead investigator for these studies.
Relmada Therapeutics to Present at the 2014 Bio International Convention
Relmada Therapeutics, which currently conducts its operations through Camp Nine, Inc. (the "Company"), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that Sergio Traversa, Chief Executive Officer, will be presenting at the 2014 BIO International Convention on Thursday, June 26, at 9:30 AM. PDT. The presentation will take place in the Solana Beach room. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego, California.